Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH

Authors: Hiroshi Iida, Masahiko Inamori, Tetsuro Fujii, Yusuke Sekino, Hiroki Endo, Kunihiro Hosono, Takashi Nonaka, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Eiji Gotoh, Shin Maeda, Atsushi Nakajima

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

The ideal medication for acid-related diseases should have a rapid onset of action to promote hemostasis and cause efficient resolution of symptoms. The aim of our study was to comparatively investigate the inhibitory effect on gastric acid secretion of a single oral administration of omeprazole plus mosapride with that of omeprazole alone.

Methods

Ten Helicobacter pylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 6 hours after a single oral administration of omeprazole 20 mg or that of omeprazole 20 mg plus mosapride 5 mg (the omeprazole being administered one hour after the mosapride). Each administration was separated by a 7-days washout period.

Results

The average pH during the 6-hour period after administration of omeprazole 20 mg plus mosapride 5 mg was higher than that after administration of omeprazole 20 mg alone (median: 3.22 versus 4.21, respectively; p = 0.0247).

Conclusions

In H. pylori -negative healthy male subjects, an oral dose of omeprazole 20 mg plus mosapride 5 mg increased the intragastric pH more rapidly than omeprazole 20 mg alone.
Appendix
Available only for authorised users
Literature
1.
go back to reference Green FW, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978, 74: 38-43.PubMed Green FW, Kaplan MM, Curtis LE, Levine PH: Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 1978, 74: 38-43.PubMed
2.
go back to reference Burget DW, Chiverton SG, Hunt RH: Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990, 99: 345-51.CrossRefPubMed Burget DW, Chiverton SG, Hunt RH: Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology. 1990, 99: 345-51.CrossRefPubMed
3.
go back to reference Iida H, Inamori M, Nozaki Y, et al: Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values. BMC Gastroenterology. 2009, 9: 52-10.1186/1471-230X-9-52.CrossRefPubMedPubMedCentral Iida H, Inamori M, Nozaki Y, et al: Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values. BMC Gastroenterology. 2009, 9: 52-10.1186/1471-230X-9-52.CrossRefPubMedPubMedCentral
4.
go back to reference Yoshikawa T, Yoshida N, Mine Y, et al: Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol. 1998, 77: 53-9. 10.1254/jjp.77.53.CrossRefPubMed Yoshikawa T, Yoshida N, Mine Y, et al: Affinity of mosapride citrate, a new gastroprokinetic agent, for 5-HT4 receptors in guinea pig ileum. Jpn J Pharmacol. 1998, 77: 53-9. 10.1254/jjp.77.53.CrossRefPubMed
5.
go back to reference Yoshida N, Ito T, Karasawa T, Itoh Z, et al: AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther. 1991, 257: 781-7.PubMed Yoshida N, Ito T, Karasawa T, Itoh Z, et al: AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther. 1991, 257: 781-7.PubMed
6.
go back to reference Okuno T, Kobayashi H, Haruki S, et al: Pharmacokinetics of FRG-8813 in Rats after Single Oral Dosing. Jpn J Pharmacol. 1995, 23: 87-104. Okuno T, Kobayashi H, Haruki S, et al: Pharmacokinetics of FRG-8813 in Rats after Single Oral Dosing. Jpn J Pharmacol. 1995, 23: 87-104.
7.
go back to reference Wei W, Ge Z-Z, Hong Lu, et al: Effect of mosapride on gastrointestinal transit time and diagnostic yield of capsule endoscopy. Gastroenterology. 2007, 22: 1605-1608. Wei W, Ge Z-Z, Hong Lu, et al: Effect of mosapride on gastrointestinal transit time and diagnostic yield of capsule endoscopy. Gastroenterology. 2007, 22: 1605-1608.
8.
go back to reference Futei S, Sugino Y, Kuribayashi S, et al: New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent. Nippon Igaku Hoshasen. 2004, 64: 22-30. Futei S, Sugino Y, Kuribayashi S, et al: New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent. Nippon Igaku Hoshasen. 2004, 64: 22-30.
9.
go back to reference Oshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T: AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn. 1989, 300: 51-67. Oshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T: AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn. 1989, 300: 51-67.
10.
go back to reference Ruth M, Hamelin B, Rohss K, Lundell L: The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998, 12: 35-40. 10.1046/j.1365-2036.1998.00268.x.CrossRefPubMed Ruth M, Hamelin B, Rohss K, Lundell L: The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998, 12: 35-40. 10.1046/j.1365-2036.1998.00268.x.CrossRefPubMed
11.
go back to reference Karamanolis G, Theofanidou I, Yiasemidou M, Giannoulis E, Triantafyllou K, Ladas SD: A glass of water immediately increases gastric pH in healthy subjects. Dig Dis Sci. 2008, 53: 3128-32. 10.1007/s10620-008-0301-3.CrossRefPubMed Karamanolis G, Theofanidou I, Yiasemidou M, Giannoulis E, Triantafyllou K, Ladas SD: A glass of water immediately increases gastric pH in healthy subjects. Dig Dis Sci. 2008, 53: 3128-32. 10.1007/s10620-008-0301-3.CrossRefPubMed
12.
go back to reference Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A: Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?. J Gastroenterol. 2005, 40: 453-8. 10.1007/s00535-005-1569-0.CrossRefPubMed Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A: Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?. J Gastroenterol. 2005, 40: 453-8. 10.1007/s00535-005-1569-0.CrossRefPubMed
13.
go back to reference Abe Y, Inamori M, Togawa J, et al: The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J Gastroenterol. 2004, 39: 21-5. 10.1007/s00535-003-1240-6.CrossRefPubMed Abe Y, Inamori M, Togawa J, et al: The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH. J Gastroenterol. 2004, 39: 21-5. 10.1007/s00535-003-1240-6.CrossRefPubMed
14.
go back to reference Inamori M, Togawa J, Chiguchi G, et al: The Evaluation of Anti-secretory Drugs on Intragastric Acidity; Are the Combined Therapy of a Proton Pump Inhibitor and a H2 Receptor Antagonist Effective as an Initial Treatment?. J Gastroenterol. 2005, 40: 213-4. 10.1007/s00535-004-1521-8.CrossRefPubMed Inamori M, Togawa J, Chiguchi G, et al: The Evaluation of Anti-secretory Drugs on Intragastric Acidity; Are the Combined Therapy of a Proton Pump Inhibitor and a H2 Receptor Antagonist Effective as an Initial Treatment?. J Gastroenterol. 2005, 40: 213-4. 10.1007/s00535-004-1521-8.CrossRefPubMed
15.
go back to reference Inamori M, Akimoto K, Akiyama T, et al: Is Oral Combination Therapy with a Proton Pump Inhibitor and H2 Receptor Antagonist Effective as Initial Treatment?. J Gastroenterol. 2007, 42: 510-1. 10.1007/s00535-007-2024-1.CrossRefPubMed Inamori M, Akimoto K, Akiyama T, et al: Is Oral Combination Therapy with a Proton Pump Inhibitor and H2 Receptor Antagonist Effective as Initial Treatment?. J Gastroenterol. 2007, 42: 510-1. 10.1007/s00535-007-2024-1.CrossRefPubMed
Metadata
Title
Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH
Authors
Hiroshi Iida
Masahiko Inamori
Tetsuro Fujii
Yusuke Sekino
Hiroki Endo
Kunihiro Hosono
Takashi Nonaka
Tomoko Koide
Hirokazu Takahashi
Masato Yoneda
Ayumu Goto
Yasunobu Abe
Noritoshi Kobayashi
Hiroyuki Kirikoshi
Kensuke Kubota
Satoru Saito
Eiji Gotoh
Shin Maeda
Atsushi Nakajima
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-25

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue